Literature DB >> 30746171

Detection of epidermal growth factor receptor mutations in circulating tumor DNA: reviewing BENEFIT clinical trial.

Umberto Malapelle1, Luis E Raez2, Maria Jose Serrano3,4, Christian Rolfo5.   

Abstract

Entities:  

Year:  2018        PMID: 30746171      PMCID: PMC6344757          DOI: 10.21037/jtd.2018.11.22

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  2 in total

1.  Can liquid biopsy-guided EGFR-targeted therapy be a surrogate for the tissue-based standard approach?

Authors:  In-Jae Oh
Journal:  Transl Lung Cancer Res       Date:  2019-12

2.  Relationship between performance status or younger age and osimertinib therapy in T790M-positive NSCLC: are the available data convincing?

Authors:  Umberto Malapelle; Antonio Rossi; Emilio Bria
Journal:  J Thorac Dis       Date:  2019-09       Impact factor: 2.895

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.